Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small yet ...

In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

As per a new study, the potential of mRNA vaccines offers a personalized treatment for patients with pancreatic cancer.

Imagine a cancer treatment that precisely targets malignant cells, leaving healthy ones untouched. Consider, also, a cancer treatment that corrects abnormal protein synthesis to produce healthy ...